Homology modelling of human CYP2 family enzymes based on the CYP2C5 crystal structure

References

• ANDREWS, P. R., CRAIK, D. J. and MARTIN, J. L., 1984, Functional group contributions to drug—receptor interactions. Journal of Medicinal Chemistry, 28, 1648–1657.
   Google Scholar
• ANZENBACHER, P. and ANZENBACHEROVA, E., 2001, Cytochromes P450 and metabolism of xenobiotics. Cellular and Molecular Life Sciences, 58, 737–747.
   PubMed Web of Science ®Google Scholar
• BOUM, H.-J., 1994, The development of a simple empirical scoring function to estimate the binding constant for a protein ligand of known 3-dimensional structure. Journal of Computer-Aided Molecular Design, 8, 243–256.
   PubMedGoogle Scholar
• CHANG, Y. T., STIFFELMAN, O. B., VASKER, I. A., LOEW, G. H., BRIDGES, A. and WASKEL L., 1997, Construction of a 3D model of cytochrome P4502B4. Protein Engineering, 10, 119–129.
   PubMedGoogle Scholar
• CHEN, C.-D. and KEMPER, B., 1996, Different structural requirements at specific proline residue positions in the conserved proline-rich region of cytochrome P450 2C2, Journal of Biological Chemistry, 271, 28607–28611.
   Google Scholar
• DE, R., PINCUS, M. R. and FRIEDMAN, F. K., 2000, Molecular modelling of mammalian cytochrome P450s. Cellular and Molecular Life Sciences, 57, 487–499.
   PubMedGoogle Scholar
• DE GROOT, M. J., ACKLAND, M. J., HORNE, V. A., ALEX, A. A. and JoNEs, B. C., 1999, Novel approach to predicting P450-mediated drug metabolism: development of a combined protein and pharmacophore model for CYP2D6. Journal of Medicinal Chemistry, 42, 1515–1524.
   PubMed Web of Science ®Google Scholar
• ELLIS, S. W., HAYHURST, G. P., SMITH, G., LIGHTFOOT, R., WONG, M. M. S., SIMULA, A. P., ACKLAND, M. J., STERNBERG, M. J. E., LENNARD, M. S., TUCKER, G. T. and WOLF, C. R., 1995, Evidence that aspartic acid 301 is a critical substate-contact residue in the active site of cytochrome P450 2D6. Journal of Biological Chemistry, 270, 29055–29058.
   Google Scholar
• FALETTO, M. B., LINKO, P. and GOLDSTEIN, J. A., 1992, A single amino acid mutation, Ser180, Cys, determines the polymorphism in cytochrome P450g, P4502C13, by altering protein stability, Journal of Biological Chemistry, 267, 2032–2037.
   Google Scholar
• GOTOH, O., 1992, Substrate recognition sites in cytochrome P450 family 2 (CYP2) proteins inferred from comparative analyses of amino acid and coding nucleotide sequences, Journal of Biological Chemistry, 267, 83–90.
   Google Scholar
• HAINING, R. L., JONES, J. P., HENNE, K. R., FISHER, M. B. and KOOP, D. R., 1999, Enzymatic determinants of the substrate specificity of CYP2C9: role of B-C loop residues in providing the pi-stacking anchor site for warfarin binding. Biochemistry, 38, 3225–3292.
   Google Scholar
• HANIOKA, N., GONZALEZ, F. J., LINDBERG, N. A., Liu, G., GELBOIN, H. V. and KORZEKWA, K. R., 1992, Site-directed mutagenesis of cytochrome P450s CYP2A1 and CYP2A2: influence of the distal helix on the kinetics of testosterone metabolism. Biochemistry, 31, 3364–3370.
   PubMed Web of Science ®Google Scholar
• HSU, M.-H., GRIFFIN, K. J., WANG, Y., KEMPER, B. and JOHNSON, E. F., 1993, A single amino acid substitution confers progesterone 6, -hydroxylase activity to rabbit cytochrome P450 2C3, Journal of Biological Chemistry, 268, 6939–6944.
   Google Scholar
• IBEANU, G. C., GHANAYEN, B. I., LINKO, P., Li, L., PEDERSEN, L. G. and GOLDSTEIN, J. A., 1996, Identification of residues 99, 220, and 221 of human cytochrome P450 2C19 as key determinants of omeprazole hydroxylase activity, Journal of Biological Chemistry, 271, 12496–12501.
   Google Scholar
• IMM, Y. and NAKAMURA, M., 1989, Point mutations at threonine-301 modify substrate specificity of rabbit liver microsomal cytochromes P-450 (laurate, co-1) -hydroxylase and testosterone 16a-hydroxylase), Biochemical and Biophysical Research Communications, 158, 717–722.
   Google Scholar
• KAMINSKY, L. S. DE MORAIS, S. M. F. FALETTO, M. B., DUNBAR, D. A. and GOLDSTEIN, J. A., 1993, Correlation of human cytochrome P4502C substrate specificities with primary structure: warfarin as a probe, Molecular Pharmacology, 43, 234–239.
   Google Scholar
• KRONBACH, T., LARABEE, T. M. and JOHNSON, E. F., 1989, Hybrid cytochromes P-450 identify a substrate binding domain in P-450I105 and P450I1C4, Proceedings of the National Academy of Sciences, USA, 86, 8262–8265.
   Google Scholar
• LEWIS, D. F. V., 1996, Cytochromes P450: Structure, Function and Mechanism (London: Taylor & Francis).
   Google Scholar
• LEWIS, D. F. V., 1998, The CYP2 family: models, mutants and interactions. Xenobiotica, 28, 617–661.
   PubMed Web of Science ®Google Scholar
• LEWIS, D. F. V., 2000, On the recognition of mammalian microsomal cytochrome P450 substrates and their characteristics. Biochemical Pharmacology, 60, 293–306.
   PubMed Web of Science ®Google Scholar
• LEWIS, D. F. V., 2001, Guide to Cytochromes P450 Structure and Function (London: Taylor & Francis).
   Google Scholar
• LEWIS, D. F. V., DICKINS, M., EDDERSHAW, P. J., GOLDFARB, P. S. and TARBIT, M. H., 1998, Molecular modelling of human CYP2C subfamily enzymes CYP2C9 and CYP2C19: rationalization of substrate specificity and site-directed mutagenesis experiments in the CYP2C subfamily. Xenobiotica, 28, 235–268.
   Google Scholar
• LEWIS, D. F. V., DICKINS, M., LAKE, B. G., EDDERSHAW, P. J., TABIT, M. H. and GOLDFARB, P. S., 1999c, Molecular modelling of the human cytochrome P450 isoforrn CYP2A6 and investigations of CYP2A substrate selectivity. Toxicology, 133, 1–33.
   Google Scholar
• LEWIS, D. F. V., EDDERSHAW, P. J., GOLDFARB, P. S. and TARBIT, M. H., 1996, Molecular modelling of CYP3A4 from an alignment with CYP102: identification of key interactions between putative active site residues and CYP3A-specific chemicals. Xenobiotica, 26, 1067–1086.
   Google Scholar
• LEWIS, D. V. F., EDDERSHAW, P. J., GOLDFARB, P. S. and TARBIT, M. H., 1997, Molecular modelling of cytochrome P4502D6 (CYP2D6) based on an alignment with CYP102: Structural studies on specific CYP2D6 substrate metabolism. Xenobiotica, 27, 319–340.
   Google Scholar
• LEWIS, D. F. V., LAKE, B. G., BIRD, M. G., DICKINS, M., EDDERSHAW, P. J., TARBIT, M. H. and GOLDFARB, P. S., 2000, Molecular modelling of human CYP2E1 by homology with the CYP102 haemoprotein domain: investigation of the interactions of substrates and inhibitors within the putative active site of the CYP2E1 isoform. Xenobiotica, 30, 1–25.
   Google Scholar
• LEWIS, D. F. V., LAKE, B. G., DICKENS, M., EDDERSHAW, P. J., TARBIT, M. H. and GOLDFARB, P. S., 1999a, Molecular modelling of the phenobarbital-inducible P450 isoforms: CYP2B1, CYP2B4 and CYP2B6 by homology with the substrate-bound CYP102 crystal structure, and evaluation of CYP2B substrate binding affinity. Xenobiotica, 29, 361–393.
   Google Scholar
• LEWIS, D. F. V., LAKE, B. G., GEORGE, S. G., DICKINS, M., BERESFORD, A. P., EDDERSHAW, P. J., TARBIT, M. H., GOLDFARB, P. S. and GUENGERICH, F. P., 1999b, Molecular modelling of CYP1 family isoforms: CYP1A1, CYP1A2, CYP1A6 and CYP1B1 based on sequence homology with CYP102. Toxicology, 139, 53–79.
   Google Scholar
• LEWIS, D. F. V., MODI, S. and DICKINS, M., 2002, Structure-activity relationships for human cytochrome P450 substrates and inhibitors. Drug Metabolism Reviews (in press).
   Google Scholar
• Li, H. and Potmos, T. L., 1997, The structure of the cytochrome P450BM-3 haem domain complexed with the fatty acid substrate, palmitoleic acid. Nature and Structural Biology, 4, 140–146.
   PubMedGoogle Scholar
• LINDBERG, R. L. P. and NEGISHI, M., 1989, Alteration of mouse cytochrome P450coh substrate specificity by mutation of a single amino acid residue. Nature, 339, 632–674.
   Google Scholar
• OHGIYA, S., KOMORI, M., OHI, H., SHIRAMATSU, K., SHINRIKI, N. and KAMATAKI, T., 1992, Six-base deletion occurring in messages of human cytochrome P-450 in the CYP2C subfamily results in reduction of tolbutamide hydroxylase activity, Biochemistry International, 27, 1073–1081.
   Google Scholar
• RAMARAO, M. K., STRAUB, P. and KEMPER, B., 1995, Identification by in vitro mutagenesis of the interaction of two segments of C2MstC1, a chimera of cytochromes P450 2C2 and P450 2C1, Journal of Biological Chemistry, 270, 1873–1880.
   Google Scholar
• RAVICHANDRAN, K. G., BODDUPALLI, S. S., HASEMANN, C. A., PETERSON, J. A. and DEISENHOFER, J., 1993, Crystal structure of hemoprotein domain of P450BM-3, a prototype for microsomal P450s. Science, 261, 731–736.
   PubMed Web of Science ®Google Scholar
• RENDIC, S. and DICARLo, F. J., 1997, Human cytochrome P450 enzymes: a status report summarizing their reactions, substrates, inducers and inhibitors. Drug Metabolism Reviews, 29, 413–580.
   PubMed Web of Science ®Google Scholar
• RICHARDSON, T. H. and JOHNSON, E. F., 1994, Alterations of the regiospecificity of progesterone metabolism by the mutagenesis of two key amino acid residues in rabbit cytochrome P450 2C3v. Journal of Biological Chemistry, 269, 23927–23943.
   Google Scholar
• RICHARDSON, T. H. and JOHNSON, E. F., 1996, The CYP2C subfamily. In C. Ioannides (ed.), Cytochromes P450: Metabolic and Toxicological Aspects (Boca Raton: CRC Press) pp. 161–181.
   Google Scholar
• RIDDERSTROM, M., MASIMIREMBARA, C., TRUMP-KALLMEYER, S., AHLEFELT, M., OTTER, C. and ANDERSSON, T. B., 2000, Arginines 97 and 108 in CYP2C9 are important determinants of the catalytic function. Biochemical and Biophysical Research Communications, 270, 983–987.
   PubMedGoogle Scholar
• SMITH, G., MODI, S., PILLA I., LIAN, L.-Y., SUTCLIFFE, M. J., PRITCHARD, M. P., FRIEDBERG, T., ROBERTS, G. C. K. and WOLF, C. R., 1998, Determinants of the substrate specificity of human cytochrome P450 CYP2D6: design and construction of mutant with testosterone hydroxylase activity. Biochemical Journal, 331, 783–792.
   Google Scholar
• STRAUB, P., JOHNSON, E. F. and KEMPER, B., 1993b, Hydrophobic side chain requirements for lauric acid and progesterone hydroxylation at amino acid 113 in cytochrome P450 2C2, a potential determinant of substrate specificity, Archives of Biochemistry and Biophysics, 306, 521–527.
   Google Scholar
• STRAUB, P., LLOYD, M., JOHNSON, E. F. and KEMPER, B., 1993a, Cassette mutagenesis of a potential substrate recognition region of cytochrome P450 2C2, Journal of Biological Chemistry, 268, 21997–22003.
   Google Scholar
• SZKLARZ, G. D., HE, Y. Q., KEDZIE, K. M., HALPERT, J. R. and BURNETT, V. L., 1996, Elucidation of amino acid residues critical for unique activities of rabbit cytochrome P4502B5 using hybrid enzymes and reciprocal site-directed mutagenesis with rabbit cytochrome P4502B4. Archives of Biochemistry and Biophysics, 327, 308–318.
   PubMedGoogle Scholar
• VERONESE, M. E., DOECKE, C. J., MACKENZIE, P. I., McMANus, M. E., MINERS, J. O., REES, D. L. P., GASSER, R., MEYER, U. A. and BIRKETT, D. J., 1993, Site-directed mutation studies of human liver cytochrome P-450 isoenzymes in the CYP2C subfamily, Biochemical Journal, 289, 533–538.
   Google Scholar
• VON WACHENFELDT, C. and JOHNSON, E. F., 1995, Structures of eukaryotic cytochrome P450 enzymes. In P. R. Ortiz de Montellano (ed.), Cytochronze P450 (New York: Plenum), pp. 183–244.
   Google Scholar
• WILLIAMS, D. H., Cox, J. P. L., DOIG, A. J., GARDNER, M., GERHARD, U., KAYE, P. T., LAL, A. R., Nicuous, I. A., SALTER, C. J. and MITCHELL, R. C., 1991, Toward the semiquantitative estimation of binding constants. Journal of the American Chemical Society, 113, 7020–7030.
   Google Scholar
• WILLIAMS, P. A., COSME, J., SRIDHAR, V., JOHNSON, E. F. and McREE, D. E., 2000, Mammalian microsomal cytochrome P450 monooxygenase: structure adaptions for membrane binding and functional diversity. Molecular Cell, 5, 121–131.
   PubMed Web of Science ®Google Scholar
• YAMAZAKI, S., SATO, K., SUHAKA, K., SAKAGUCHI, M., MIHARA, K. and OMURA, T., 1993, Importance of the proline-rich region following signal-anchor sequence in the formation of correct conformation of microsomal cytochrome P-450s, Journal of Biochemistry, 114, 652–657.
   Google Scholar